Could a Parkinson's drug protect eyesight in diabetes?
NCT ID NCT05132660
First seen Apr 21, 2026 · Last updated May 01, 2026 · Updated 2 times
Summary
This early-phase study tests whether levodopa, a drug used for Parkinson's disease, can slow the development of blood vessel changes in the eyes of people with diabetes. Researchers will measure the retina's electrical activity and use eye imaging to track changes over time. The study enrolls 244 adults with diabetes who have early signs of retinal stress but no advanced eye disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, 30033-4004, United States
Conditions
Explore the condition pages connected to this study.